News

Clinical data show that the patient group receiving Rinvoq treatment achieved statistically significant improvement in core indicators such as disease activity index scores and swollen/tender joint counts. This result further consolidates Rinvoq’s clinical position as an important treatment option for patients with moderate to severe active rheumatoid arthritis.

This statement highlights the activist investor's concern about Dynatrace's current strategic direction and corporate governance. Starboard pointed out that, in order to fully maximize shareholder value, the Dynatrace leadership team should not be limited to the existing operating model, but should actively evaluate all viable options, including business optimization, capital structure adjustments, and even potential strategic transactions. These remarks suggest that Starboard may push this software intelligence company toward deeper transformation.

The company’s management is actively reviewing various business opportunities in order to effectively offset the pressure from rising operating costs. In response to the current cost structure challenges faced by the aviation industry, the airline emphasized that it will maintain financial resilience through dynamic cost control mechanisms. Its strategic deployment not only focuses on short-term benefits, but also places greater importance on building a long-term sustainable cost competitive advantage.